# MVP-001 Independent Reviewer / Red Team

## Review scope

Fresh-context reviewer; read-only. Reviewed the MVP-001 Cell-Line Core design,
data audits, exact-978 observed oracle, learned Delta978 diagnostic, predicted
reversal, compact PRISM evaluation, governance record, and validation log.

## Review history

The first pass identified and required correction of an implementation branch
that emitted unsupported `PARTIAL`, absence of a committed RESULT REVIEWED
checkpoint, and incomplete PRISM identity metadata checksums. The Manager fixed
the status vocabulary, added tracked manifest/provenance and identity checksums,
and reran the project checks. The post-fix review is recorded below.

## Post-fix verdict

`PENDING_COMMITTED_CHECKPOINT_REVIEW`

The code and metadata fixes are ready for a local candidate commit. The final
verdict will be written only after the reviewer has inspected that actual commit
and the tracked validation log; no reviewer conclusion is inferred by the
Manager.

## Remaining limitations (non-blocking)

- The four-drug cohort and top-2 diagnostics are MVP-scale, not paper-level evidence.
- The learned model is `NO_SIGNAL_DIAGNOSTIC`; the `PROMISING` label belongs to
  the end-to-end feasibility chain and observed/predicted PRISM directional diagnostics.
- No binary PRISM labels, AUROC/AUPRC, multi-seed statistics or formal external
  validation are claimed.

Reviewer status: follow-up requested; no code or data files modified.
